Literature DB >> 18617683

Pheochromocytoma: current approaches and future directions.

Joel T Adler1, Goswin Y Meyer-Rochow, Herbert Chen, Diana E Benn, Bruce G Robinson, Rebecca S Sippel, Stan B Sidhu.   

Abstract

Pheochromocytomas are rare catecholamine-secreting tumors that arise from chromaffin tissue within the adrenal medulla and extra-adrenal sites. Because of the excess secretion of hormones, these tumors often cause debilitating symptoms and a poor quality of life. While medical management plays a significant role in the treatment of pheochromocytoma patients, surgical excision remains the only cure. Improved medical management and surgical techniques and an increased understanding of hereditary disease have improved the outcome of pheochromocytoma patients with benign disease; however, the outcome of patients with malignant disease remains poor. In this review, we discuss the presentation, diagnosis, management, and future directions in the management of this disease.

Entities:  

Mesh:

Year:  2008        PMID: 18617683     DOI: 10.1634/theoncologist.2008-0043

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  56 in total

Review 1.  Percutaneous ablation of adrenal tumors.

Authors:  Aradhana M Venkatesan; Julia Locklin; Damian E Dupuy; Bradford J Wood
Journal:  Tech Vasc Interv Radiol       Date:  2010-06

2.  Inhibition of the PI3K pathway suppresses hormonal secretion and limits growth in pheochromocytoma cells.

Authors:  Joel T Adler; Daniel G Hottinger; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

Review 3.  Management of Adrenal Masses.

Authors:  Hattangadi Sanjay Bhat; Balagopal Nair Tiyadath
Journal:  Indian J Surg Oncol       Date:  2016-12-17

4.  Hypertension in pheochromocytoma: characteristics and treatment.

Authors:  Samuel M Zuber; Vitaly Kantorovich; Karel Pacak
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

Review 5.  Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.

Authors:  Amrish Jain; Rossana Baracco; Gaurav Kapur
Journal:  Pediatr Nephrol       Date:  2019-01-02       Impact factor: 3.714

6.  Sodium butyrate activates Notch1 signaling, reduces tumor markers, and induces cell cycle arrest and apoptosis in pheochromocytoma.

Authors:  Max A Cayo; Ashley K Cayo; Sarah M Jarjour; Herbert Chen
Journal:  Am J Transl Res       Date:  2009-01-31       Impact factor: 4.060

7.  Recurrent urinary bladder paraganglioma.

Authors:  Ali A Al-Zahrani
Journal:  Adv Urol       Date:  2010-06-27

8.  Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy.

Authors:  Yuling Xiao; Renata Jaskula-Sztul; Alireza Javadi; Wenjin Xu; Jacob Eide; Ajitha Dammalapati; Muthusamy Kunnimalaiyaan; Herbert Chen; Shaoqin Gong
Journal:  Nanoscale       Date:  2012-11-21       Impact factor: 7.790

9.  A Peculiar Primary Paraganglioma of the Distal Thumb.

Authors:  Sarah T Lander; Erin Coppola; Wakenda Tyler; John C Elfar
Journal:  J Hand Surg Am       Date:  2016-03-09       Impact factor: 2.230

10.  Histone deacetylase inhibitors upregulate Notch-1 and inhibit growth in pheochromocytoma cells.

Authors:  Joel T Adler; Daniel G Hottinger; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.